UPDATES IN THE CLINICAL DEVELOPMENT OF EPACADOSTAT AND OTHER INDOLEAMINE 2,3-DIOXYGENASE 1 INHIBITORS (IDO1) FOR HUMAN CANCERS

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers

Recent application of immunotherapy in clinical oncology revolutionized our management of advanced human cancers.Check point inhibitors targeting CTLA4 and PD-1/PD-L1 axis are immunotherapeutic agents currently available to treat a variety of cancers.However, a novel therapeutic approach is needed to further improve patient outcome with these Comb

read more

Local synteny and codon usage contribute to asymmetric sequence divergence of Saccharomyces cerevisiae gene duplicates

Abstract Background Duplicated genes frequently experience asymmetric rates of sequence evolution.Relaxed selective constraints and positive selection have both been invoked to explain the observation that one paralog within a gene-duplicate pair exhibits an accelerated rate of sequence evolution.In the majority of studies where asymmetric divergen

read more